Differential diagnosis of suspected multiple sclerosis: considerations in people from minority ethnic and racial backgrounds in North America, northern Europe, and Australasia
Lilyana Amezcua(University of Southern California), Walter Royal(Morehouse School of Medicine), Daniel Ontaneda(University of British Columbia Hospital), Ruth Dobson(Queen Mary University of London), Bernhard Hemmer(TUM Klinikum), Dorlan Kimbrough(Johns Hopkins University), Bruce Taylor(Royal Hobart Hospital), Afsaneh Shirani(University of Nebraska Medical Center), Dalia Rotstein(St. Michael's Hospital), Brenda Banwell(University of Toronto), Scott D. Newsome(Johns Hopkins University), Mitzi Williams(Morehouse School of Medicine), Ruth Ann Marrie(Manitoba Health), Olga Ciccarelli(National Institute for Health and Care Research), Víctor M. Rivera(Baylor College of Medicine), Melinda Magyari(University of Copenhagen), Jeffrey Cohen(Cleveland Clinic), Andrew Solomon(University of Vermont)
Cited by 11
Related Papers
Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria
|The Lancet Neurology|2017|8k
International consensus diagnostic criteria for neuromyelitis optica spectrum disorders
|Neurology|2015|4.6k
Defining the clinical course of multiple sclerosis
|Neurology|2014|3.1k
Rising prevalence of multiple sclerosis worldwide: Insights from the Atlas of MS, third edition
|Multiple Sclerosis Journal|2020|2.5k
Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis
|New England Journal of Medicine|2016|2k